NeurorehabilitationNCT05855096
Clinical Assessment And Treatment Preferences of Physiotherapists Working in Neurorehabilitation: A Research From Turkey
An observational study of Neurorehabilitation and Physiotherapist, run by Biruni University at 1 site in Turkey (Türkiye).
Trial summary
The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. Read more about this study
- Who is it for?
- Ages 25 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Neurorehabilitation, Physiotherapist, Clinical Assessment
- What is being tested?
- Google Form Questionnaire
- How many people
- 95 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 17 Apr 2023to 30 May 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Physiotherapists who can read and understand Turkish and have at least three years of work experience will be included in the study. It is planned to send the questionnaire prepared via Google Survey to physiotherapists working in the field via non-governmental organizations, social media and association mails. In the questionnaire, it was aimed to question the age, gender, duration of work in the profession, the duration of work in the field of neurorehabilitation, the training received after graduation, the most preferred evaluation and treatment methods for neurological diseases that are mostly encountered in the field.
Who may be able to join
- Having at least 3 years of patient follow-up experience in the field of neurorehabilitation
- Men and women of all age groups who are in the active working process physiotherapists
- Being a volunteer
- Speaks and understands the Turkish language (for foreign nationals)
Who cannot join
- Respondents who did not or incompletely answered parts of the survey
Trial locations and contacts
1 site in 1 country.
About this study
The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation. There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The aim of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neurorehabilitation in Turkey.
Read the detailed description
Rehabilitation is a part of health services performed in many diseases and specific areas. It has four stages, and these are prevention, enhancement, treatment and protection. The main purpose of rehabilitation programs is independence in activities. It is to increase the quality of life and social adaptation of the patient by protecting the patient, minimizing pain and disability, and improving the ability to adapt to changing conditions. Neurological problems are one of the areas that often need rehabilitation. Millions of people worldwide are affected by neurodegenerative problems. According to the data shared by the World Health Organization (WHO), many of the neurological disorders are chronic and progressive, creating a global picture. Neurological problems negatively affect the health of the individual in many ways. To improve the physical and emotional functions, quality of life and social participation levels of individuals with neurological disease, it is necessary to know the limitations they experience due to neurological disease very well. The causes of neurological problems can vary from person to person and from problem to problem. These causes may include genetic disorders, congenital abnormalities or disorders, infections, lifestyle, or environmental health issues, including malnutrition, brain injury, spinal cord injury, nerve injury [8,9]. In addition, the neurological problem may begin in another system that interacts with the nervous system. For example, stroke (cerebrovascular accident), includes brain damage caused by problems with the blood vessels that feed the brain (cardiovascular system); autoimmune disorders, caused by the body's own immune system includes damage. Neurological diseases bring with them secondary problems besides primary problems. These secondary problems and deformities negatively affecting function, productivity and participation, which are essential components of their activities, restricts the independence of the individual. Pertaining to the motor and sensory systems seen in neurological diseases. The problems are often accompanied by cognitive, behavioural, sensory, communication and perception disorders. is seen. It is known that participation in daily life activities is one of the elements that increase the creativity of individuals, improve their skills and enable them to integrate into social life .By identifying the limitations experienced by individuals due to neurological disease. Improving their quality of life and social participation levels is the most basic of rehabilitation is the target. The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation.There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The purpose of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neuro rehabilitation in Turkey.
- Being tested
- Google Form Questionnaire
- Keywords
- neurorehabilitation, physiotherapist, perspectives
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Google Form QuestionnaireOther
Google form questionnaire is performed by responders.
What is being measured
The primary outcome is the main question the study is designed to answer.
Google Form Questionnaire
It is planned to send the questionnaire prepared via Google Questionnaire to the physiotherapists who accept to participate in the research and meet the inclusion criteria, to the physiotherapists working in the field via social media, the Physiotherapists Association of Turkey and its sub-groups registered members after the necessary permissions are obtained.
Measured: 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 May 2023
- Study start17 Apr 2023
- Primary completion24 Apr 2023
- Study completion30 May 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for NeurorehabilitationStudies of the same condition, open and under way.
- More trials run by Biruni UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 95 participants (actual)
Sponsor and investigators
- Lead sponsor
- Biruni University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Guzin Kaya Aytutuldu, Biruni University
- Investigators
- Guzin Kaya Aytutuldu, Principal investigator, Biruni University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05855096
- Sponsor's protocol ID
- Biruni Un
- Status last verified
- Feb 2024
- First submitted
- 3 May 2023
- Last updated
- 14 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Krug E, Cieza A. Strengthening Health Systems to Provide Rehabilitation Services. Ann Rehabil Med. 2017 Apr;41(2):169-170. doi: 10.5535/arm.2017.41.2.169. Epub 2017 Apr 27. No abstract available.
PubMed 28503447Wade DT. What is rehabilitation? An empirical investigation leading to an evidence-based description. Clin Rehabil. 2020 May;34(5):571-583. doi: 10.1177/0269215520905112. Epub 2020 Feb 10.
PubMed 32037876Guerra-Vazquez CM, Martinez-Avila M, Guajardo-Flores D, Antunes-Ricardo M. Punicic Acid and Its Role in the Prevention of Neurological Disorders: A Review. Foods. 2022 Jan 18;11(3):252. doi: 10.3390/foods11030252.
PubMed 35159404Ona ED, Cano-de la Cuerda R, Sanchez-Herrera P, Balaguer C, Jardon A. A Review of Robotics in Neurorehabilitation: Towards an Automated Process for Upper Limb. J Healthc Eng. 2018 Apr 1;2018:9758939. doi: 10.1155/2018/9758939. eCollection 2018.
PubMed 29707189Lexell J, Brogardh C. The use of ICF in the neurorehabilitation process. NeuroRehabilitation. 2015;36(1):5-9. doi: 10.3233/NRE-141184.
PubMed 25547759Zis P, Hadjivassiliou M. Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease. Curr Treat Options Neurol. 2019 Feb 26;21(3):10. doi: 10.1007/s11940-019-0552-7.
PubMed 30806821Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009 Jan-Mar;24(1):15-45. doi: 10.1515/reveh.2009.24.1.15.
PubMed 19476290McDowell FH. Neurorehabilitation. West J Med. 1994 Sep;161(3):323-7. No abstract available.
PubMed 7975575Tempest S, Jefferson R. Engaging with clinicians to implement and evaluate the ICF in neurorehabilitation practice. NeuroRehabilitation. 2015;36(1):11-5. doi: 10.3233/NRE-141185.
PubMed 25547760Krucoff MO, Rahimpour S, Slutzky MW, Edgerton VR, Turner DA. Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation. Front Neurosci. 2016 Dec 27;10:584. doi: 10.3389/fnins.2016.00584. eCollection 2016.
PubMed 28082858van den Broek MD. Why does neurorehabilitation fail? J Head Trauma Rehabil. 2005 Sep-Oct;20(5):464-73. doi: 10.1097/00001199-200509000-00007.
PubMed 16170254
Study at a glance
From the registry record, last updated by the sponsor on 14 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Assessment And Treatment Preferences of Physiotherapists Working in Neurorehabilitation: A Research From Turkey
- ClinicalTrials.gov ID
- NCT05855096
- Acronym / sponsor ID
- Biruni Un
- Keywords
- neurorehabilitation, physiotherapist, perspectives
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 95 participants (actual)
- Lead sponsor
- Biruni UniversityUniversity, hospital or other
- Study start
- 17 Apr 2023 (actual)
- Primary completion
- 24 Apr 2023 (actual)
- Study completion
- 30 May 2023 (actual)
- First posted
- 11 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation. There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The aim of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neurorehabilitation in Turkey.
Detailed description
Rehabilitation is a part of health services performed in many diseases and specific areas. It has four stages, and these are prevention, enhancement, treatment and protection. The main purpose of rehabilitation programs is independence in activities. It is to increase the quality of life and social adaptation of the patient by protecting the patient, minimizing pain and disability, and improving the ability to adapt to changing conditions. Neurological problems are one of the areas that often need rehabilitation. Millions of people worldwide are affected by neurodegenerative problems. According to the data shared by the World Health Organization (WHO), many of the neurological disorders are chronic and progressive, creating a global picture. Neurological problems negatively affect the health of the individual in many ways. To improve the physical and emotional functions, quality of life and social participation levels of individuals with neurological disease, it is necessary to know the limitations they experience due to neurological disease very well. The causes of neurological problems can vary from person to person and from problem to problem. These causes may include genetic disorders, congenital abnormalities or disorders, infections, lifestyle, or environmental health issues, including malnutrition, brain injury, spinal cord injury, nerve injury [8,9]. In addition, the neurological problem may begin in another system that interacts with the nervous system. For example, stroke (cerebrovascular accident), includes brain damage caused by problems with the blood vessels that feed the brain (cardiovascular system); autoimmune disorders, caused by the body's own immune system includes damage. Neurological diseases bring with them secondary problems besides primary problems. These secondary problems and deformities negatively affecting function, productivity and participation, which are essential components of their activities, restricts the independence of the individual. Pertaining to the motor and sensory systems seen in neurological diseases. The problems are often accompanied by cognitive, behavioural, sensory, communication and perception disorders. is seen. It is known that participation in daily life activities is one of the elements that increase the creativity of individuals, improve their skills and enable them to integrate into social life .By identifying the limitations experienced by individuals due to neurological disease. Improving their quality of life and social participation levels is the most basic of rehabilitation is the target. The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation.There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The purpose of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neuro rehabilitation in Turkey.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 25 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Physiotherapists who can read and understand Turkish and have at least three years of work experience will be included in the study. It is planned to send the questionnaire prepared via Google Survey to physiotherapists working in the field via non-governmental organizations, social media and association mails. In the questionnaire, it was aimed to question the age, gender, duration of work in the profession, the duration of work in the field of neurorehabilitation, the training received after graduation, the most preferred evaluation and treatment methods for neurological diseases that are mostly encountered in the field.
Key inclusion criteria (4 listed)
- Having at least 3 years of patient follow-up experience in the field of neurorehabilitation
- Men and women of all age groups who are in the active working process physiotherapists
- Being a volunteer
- Speaks and understands the Turkish language (for foreign nationals)
Key exclusion criteria (1 listed)
- Respondents who did not or incompletely answered parts of the survey
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Google Form QuestionnaireGoogle form questionnaire is performed by responders. | Other | – |
Primary outcome
Google Form Questionnaire
Time frame: 5 minutes
It is planned to send the questionnaire prepared via Google Questionnaire to the physiotherapists who accept to participate in the research and meet the inclusion criteria, to the physiotherapists working in the field via social media, the Physiotherapists Association of Turkey and its sub-groups registered members after the necessary permissions are obtained.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Feb 2024.
- Background: PubMed 28503447Krug E, Cieza A. Strengthening Health Systems to Provide Rehabilitation Services. Ann Rehabil Med. 2017 Apr;41(2):169-170. doi: 10.5535/arm.2017.41.2.169. Epub 2017 Apr 27. No abstract available.
- Background: PubMed 32037876Wade DT. What is rehabilitation? An empirical investigation leading to an evidence-based description. Clin Rehabil. 2020 May;34(5):571-583. doi: 10.1177/0269215520905112. Epub 2020 Feb 10.
- Background: PubMed 35159404Guerra-Vazquez CM, Martinez-Avila M, Guajardo-Flores D, Antunes-Ricardo M. Punicic Acid and Its Role in the Prevention of Neurological Disorders: A Review. Foods. 2022 Jan 18;11(3):252. doi: 10.3390/foods11030252.
- Background: PubMed 29707189Ona ED, Cano-de la Cuerda R, Sanchez-Herrera P, Balaguer C, Jardon A. A Review of Robotics in Neurorehabilitation: Towards an Automated Process for Upper Limb. J Healthc Eng. 2018 Apr 1;2018:9758939. doi: 10.1155/2018/9758939. eCollection 2018.
- Background: PubMed 25547759Lexell J, Brogardh C. The use of ICF in the neurorehabilitation process. NeuroRehabilitation. 2015;36(1):5-9. doi: 10.3233/NRE-141184.
- Background: PubMed 30806821Zis P, Hadjivassiliou M. Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease. Curr Treat Options Neurol. 2019 Feb 26;21(3):10. doi: 10.1007/s11940-019-0552-7.
- Background: PubMed 19476290Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009 Jan-Mar;24(1):15-45. doi: 10.1515/reveh.2009.24.1.15.
- Background: PubMed 7975575McDowell FH. Neurorehabilitation. West J Med. 1994 Sep;161(3):323-7. No abstract available.
- Background: PubMed 25547760Tempest S, Jefferson R. Engaging with clinicians to implement and evaluate the ICF in neurorehabilitation practice. NeuroRehabilitation. 2015;36(1):11-5. doi: 10.3233/NRE-141185.
- Background: PubMed 28082858Krucoff MO, Rahimpour S, Slutzky MW, Edgerton VR, Turner DA. Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation. Front Neurosci. 2016 Dec 27;10:584. doi: 10.3389/fnins.2016.00584. eCollection 2016.
- Background: PubMed 16170254van den Broek MD. Why does neurorehabilitation fail? J Head Trauma Rehabil. 2005 Sep-Oct;20(5):464-73. doi: 10.1097/00001199-200509000-00007.
- Individual participant dataSharing planned: No
Related trials for Neurorehabilitation
Not yet recruiting
Virtual Reality Training Dose for Arm Recovery After Stroke: Clinical and Blood Biomarker Responses
Stroke, Upper Extremity Paresis
RecruitingPhase 2
tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy
Cerebral Palsy
Active, not recruiting
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Hereditary Spastic Paraplegia
Not yet recruitingEarly Phase 1
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
Spasticity, Stroke
Not yet recruiting
The Mechatronic Remote Physiotherapy System (MRPS) in Remote Stroke Rehabilitation
Stroke, Neurological Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Guzin Kaya Aytutuldu principal investigator
Biruni University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neurorehabilitation and Physiotherapist, run by Biruni University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Google Form Questionnaire (time frame: 5 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05855096, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2024.